Cathay Biotech Inc (688065) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Cathay Biotech Inc (688065) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-66.22 Million ≈ $-9.69 Million USD) by net assets (CN¥21.22 Billion ≈ $3.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review financial agility of Cathay Biotech Inc to assess the company's free cash flow relative to its total liabilities.

Cathay Biotech Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Cathay Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Cathay Biotech Inc (688065) market capitalisation for the company's overall valuation and market capitalisation.

Cathay Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cathay Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CHINA TOWER UNSP.ADR/100 F:2Y10	N/A
Soitec SA PA:SOI	0.017x
Mirvac Group AU:MGR	0.043x
INPOST S.A. EO -01 F:669	N/A
Colliers International Group Inc Bats TO:CIGI	-0.068x
Corporacion Financiera Alba SA MC:ALB	0.006x
TPG Telecom Ltd AU:TPG	0.067x
Taiwan Glass Ind Corp TW:1802	0.003x

Annual Cash Flow Conversion Efficiency for Cathay Biotech Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Cathay Biotech Inc from 2016 to 2024. View Cathay Biotech Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥15.10 Billion ≈ $2.21 Billion	CN¥820.93 Million ≈ $120.13 Million	0.054x	+41.03%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥569.45 Million ≈ $83.33 Million	0.039x	-27.87%
2022-12-31	CN¥15.04 Billion ≈ $2.20 Billion	CN¥803.67 Million ≈ $117.60 Million	0.053x	+32.10%
2021-12-31	CN¥14.69 Billion ≈ $2.15 Billion	CN¥594.18 Million ≈ $86.95 Million	0.040x	-9.78%
2020-12-31	CN¥11.48 Billion ≈ $1.68 Billion	CN¥514.96 Million ≈ $75.36 Million	0.045x	-42.12%
2019-12-31	CN¥4.64 Billion ≈ $679.25 Million	CN¥359.62 Million ≈ $52.62 Million	0.077x	+2477.46%
2018-12-31	CN¥3.16 Billion ≈ $461.93 Million	CN¥-10.29 Million ≈ $-1.51 Million	-0.003x	-113.39%
2017-12-31	CN¥2.20 Billion ≈ $321.46 Million	CN¥53.45 Million ≈ $7.82 Million	0.024x	+123.05%
2016-12-31	CN¥1.22 Billion ≈ $178.35 Million	CN¥-128.67 Million ≈ $-18.83 Million	-0.106x	--

About Cathay Biotech Inc

SHG:688065 China Chemicals

Market Cap

$5.02 Billion

CN¥34.28 Billion CNY

Market Cap Rank

#3585 Global

#506 in China

Share Price

CN¥47.53

Change (1 day)

-2.90%

52-Week Range

CN¥40.22 - CN¥62.24

All Time High

CN¥134.07